Front. Pharmacol.Frontiers in PharmacologyFront. Pharmacol.1663-9812Frontiers Media S.A.73077510.3389/fphar.2021.730775PharmacologyCorrectionCorrigendum: Tubeimoside 1 Acts as a Chemotherapeutic Synergist via Stimulating MacropinocytosisGong et al.Corrigendum: Tubeimoside 1 Stimulates MacropinocytosisGongXianling12†SunRuibo1†GaoZhuowei13†HanWeili4LiuYawei5ZhaoLiang6JingLinlin7YaoXueqing1SunXuegang1*
The Key Laboratory of Molecular Biology, State Administration of Traditional Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China
School of Pharmacy, Guangdong Medical University, Dongguan, China
Shunde Hospital, Southern Medical University, Foshan, China
School of Public Health, Guangzhou, China
Nanfang Hospital, Southern Medical University, Guangzhou, China
School of Basic Medical Sciences, Southern Medical University, Guangzhou, China
Traditional Chinese Medicine Integrated Hospital, Southern Medical University, Guangzhou, China
Approved by:Frontiers Editorial Office, Frontiers Media SA, Switzerland
*Correspondence: Xuegang Sun, sxg_smu@126.com
These authors have contributed equally to this work
This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
A Corrigendum on Tubeimoside 1 Acts as a Chemotherapeutic Synergist via Stimulating Macropinocytosis by Gong, X., Sun, R., Gao, Z., Han, W., Liu, Y., Zhao, L., Jing, L., Yao, X., and Sun X. (2018). Front. Pharmacol. 9:1044. doi:10.3389/fphar.2018.01044tubeimoside 1chemotherapeutic synergistmacropinocytosismethuosisendocytosis
In the original article, there was a mistake in Figure 6 as published.
Chloroquine suppress TBM1-induced vacuolation and cell death in CRC cells. (A) SW480 were treated with 8 μM TBM1 for different time or starvation or 1 μM rapamycin for 24 h. Protein expression of LC3-I and LC3-II was detected by Western blotting. Beta-actin were served as loading control. (B) SW480 cells were pre-cultured with or without chloroquine (CQ) (10 μM) for 1 h before exposure to TBM1 for 24 h. LC3 processing was assessed using Western blotting analysis. (C) After treatment with SW480 cells for different time as (B), morphological changes were observed by phase-contrast microscopy. (D) SW480 cells were pre-cultured with or without 3-MA (3 mM) for 1 h before exposure to TBM1 for different time. Morphological changes were observed using phase-contrast microscopy. (E) The number of vacuoles of the same cultures as (B) for 48 h was counted from three different imagines. (F) Cell viability was measured by MTT assay (n = 5). #p < 0.01.
The second image of bottom panel of Figure 6D was misused. The corrected Figure 6 appears below.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.